Skip to content

Immunoinflammatory Profiling in Heart Failure Patients

Immunoinflammatory Profiling in Heart Failure Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105674
Enrollment
Unknown
Registered
2025-07-09
Start date
2025-07-09
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Cardiomyopathy

Interventions

ICM/DCM patient group:None
Healthy control group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient group: 1. From June 2025 to June 2027, patients with confirmed ICM and DCM were hospitalized in Wuhan Union Hospital 2. Age>=18 years, gender is not limited 3. Sign the informed consent form Healthy control group: 1. All physiological and biochemical examinations are within the normal range; 2. Healthy lifestyle habits; 3. Not taking any treatment-related drugs 4. Mental health

Exclusion criteria

Exclusion criteria: 1. Abnormal renal function tests (creatinine clearance 3 times the upper limit of normal) 3. Uncontrolled infectious diseases 4. Immune diseases or immune-related diseases, such as systemic lupus erythematosus, asthma, inflammatory bowel disease, gout, malignant tumors, etc 5. Any other condition judged by the investigator that the patient is not suitable to participate in the clinical trial

Design outcomes

Primary

MeasureTime frame
Antibody;

Countries

China

Contacts

Public ContactCheng Xiang

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

nathancx@hust.edu.cn+86 27 8572 6685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026